Home Healthcare IT Short-Acting Insulin Market Size, Trends, Forecast to 2030

Short-Acting Insulin Market

Short-Acting Insulin Market Size, Share & Trends Analysis Report By Drug (Novolog, Humalog, Humulin) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI1680DR
Study Period 2018-2030 CAGR 2%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 9257 Million
Forecast Year 2030 Forecast Year Market Size USD 10288 Million
Largest Market North America Fastest Growing Market Asia Pacific
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Short-Acting Insulin Market, By Drug (2020-2030)
    1. Novolog
    2. Humalog
    3. Humulin
    1. North America
      1. North America Short-Acting Insulin Market, By Drug
        1. Novolog
          1. Humalog
            1. Humulin
            2. U.S.
              1. U.S. Short-Acting Insulin Market, By Drug
                1. Novolog
                  1. Humalog
                    1. Humulin
                  2. Canada
                2. Europe
                  1. Europe Short-Acting Insulin Market, By Drug
                    1. Novolog
                      1. Humalog
                        1. Humulin
                        2. U.K.
                          1. U.K. Short-Acting Insulin Market, By Drug
                            1. Novolog
                              1. Humalog
                                1. Humulin
                              2. Germany
                              3. France
                              4. Spain
                              5. Italy
                              6. Russia
                              7. Nordic
                              8. Benelux
                              9. Rest of Europe
                            2. APAC
                              1. APAC Short-Acting Insulin Market, By Drug
                                1. Novolog
                                  1. Humalog
                                    1. Humulin
                                    2. China
                                      1. China Short-Acting Insulin Market, By Drug
                                        1. Novolog
                                          1. Humalog
                                            1. Humulin
                                          2. Korea
                                          3. Japan
                                          4. India
                                          5. Australia
                                          6. Taiwan
                                          7. South East Asia
                                          8. Rest of Asia-Pacific
                                        2. Middle East and Africa
                                          1. Middle East and Africa Short-Acting Insulin Market, By Drug
                                            1. Novolog
                                              1. Humalog
                                                1. Humulin
                                                2. UAE
                                                  1. UAE Short-Acting Insulin Market, By Drug
                                                    1. Novolog
                                                      1. Humalog
                                                        1. Humulin
                                                      2. Turkey
                                                      3. Saudi Arabia
                                                      4. South Africa
                                                      5. Egypt
                                                      6. Nigeria
                                                      7. Rest of MEA
                                                    2. LATAM
                                                      1. LATAM Short-Acting Insulin Market, By Drug
                                                        1. Novolog
                                                          1. Humalog
                                                            1. Humulin
                                                            2. Brazil
                                                              1. Brazil Short-Acting Insulin Market, By Drug
                                                                1. Novolog
                                                                  1. Humalog
                                                                    1. Humulin
                                                                  2. Mexico
                                                                  3. Argentina
                                                                  4. Chile
                                                                  5. Colombia
                                                                  6. Rest of LATAM

                                                              Related Reports

                                                              Global Report
                                                              The global rapid-acting insulin market size was valued at USD 6.77 billion in 2021. It is expected to reach USD 9.72 billion by 2030, growing at a CAGR of 4.1% during the forecast period (2022–2030). Insulin analogs classified as rapid-acting
                                                              Buy Now

                                                              Purchase Benefits

                                                              • Eligible for a free updated report next year
                                                              • Completely customizable scope
                                                              • 30% discount on your next purchase
                                                              • Dedicated account manager
                                                              • Query resolution within 24 hours
                                                              • Permission to print the report


                                                              We are featured on :